Evidence map›Paper›PMID 10364509›Full record

ReviewAmerican journal of human genetics1999

Genetics of Angelman syndrome.

Y Jiang, E Lev-Lehman, J Bressler, T F Tsai, A L Beaudet

Abstract readReview
In one paragraph

Review in American journal of human genetics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Article
  12. Review
  13. Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Evaluation of a TrkB agonist on spatial and motor learning in theLearning & memory (Cold Spring Harbor, N.Y.) · 2020
    Article
  18. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.Autism research : official journal of the International Society for Autism Research · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Y JiangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
E Lev-Lehman
J Bressler
T F Tsai
A L Beaudet

Funding

Human neurobehavioral phenotypes associates with the extended PWS/AS domainR01HD037283 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L. · 1999 to 2014
$8.4M
NICHD NIH HHS HD 37283
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angelman SyndromeAnimalsBrainChromosomes, Human, Pair 15HumansLigasesLong-Term PotentiationMiceModels, GeneticPrader-Willi SyndromeUbiquitin-Protein LigasesUbiquitinsLigasesUbiquitin-Protein LigasesUbiquitins

Identifiers

PMID10364509
PMCPMC1378067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.